• TOC Icon

    Guillain-Barré syndrome for the nonneurologist

    Hailey Katulski, DO, Christopher Economus, MD, Benjamin Claytor, MD and Nirmal Andrapalliyal, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 679-687;
    • DOI: https://doi.org/10.3949/ccjm.93a.26049
    • The authors review the clinical presentation and differential diagnosis of Guillain-Barré syndrome, with a goal of aiding internists to better recognize and differentiate it from its mimics.

  • Harnessing the placebo effect: A practical review of mechanisms and clinical applications

    Mohamad El Zein, MD and Adele C. Viguera, MD, MPH
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 669-676;
    • DOI: https://doi.org/10.3949/ccjm.93a.25057
    • Placebo effects engage distinct neural pathways, including dopaminergic, opioidergic, and endocannabinoid systems, through which they produce measurable changes in physiology and symptoms.

  • Unilateral arm edema and drooping shoulder with intense scapular pain

    Toshimasa Yamaguchi, MD and Yuko Inoue, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 643-645;
    • DOI: https://doi.org/10.3949/ccjm.93a.26023
    • The patient’s symptoms began 4 months earlier with numbness in the upper right arm and persistent pain behind the right scapula.

  • The placebo response in medical practice: Why should we care?

    Leonard Calabrese, DO
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 677-678;
    • DOI: https://doi.org/10.3949/ccjm.93a.26085
    • The therapeutic relationship is not merely the vehicle through which care is delivered but is itself a component of treatment.

  • Managing differentiated thyroid cancer in adult patients: Review of the 2025 American Thyroid Association guidelines

    Eduardo Canalizo, MD, Judy Jin, MD, John Costin, MD, Sophia Horattas, MD, Mary Kellis, MD, Eric Lamarre, MD, Ossama Lashin, MD, PhD, Gustavo Romero-Velez, MD, Samuel Trosman, MD and Patrick Byrne, MD, MBA
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 661-666;
    • DOI: https://doi.org/10.3949/ccjm.93a.26044
    • The 2025 guidelines reflect an ongoing shift in thyroid cancer management toward risk-adapted, less aggressive care that emphasizes shared decision-making.

  • When should I use coronary artery calcium scoring to guide statin therapy decisions?

    Faysal Massad, MD, Leslie Cho, MD and Wael Jaber, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 649-652;
    • DOI: https://doi.org/10.3949/ccjm.93a.26036
    • Coronary artery calcium should be checked when there is uncertainty about starting a statin after you’ve estimated risk for atherosclerotic cardiovascular disease and considered risk enhancers.

  • Letter: Primary aldosteronism

    Daniel Weiss, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 641;
    • DOI: https://doi.org/10.3949/ccjm.93c.11001
  • Hyponatremia in a patient with breast cancer: Unraveling the cause

    CME Image
    Jonathan S. Rees, MD and Cynthia H. Ho, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 653-660;
    • DOI: https://doi.org/10.3949/ccjm.93a.26037
    • The patient presented to the emergency department after having 3 days of fatigue, dizziness, and intractable vomiting; she had been hospitalized for similar symptoms 1 month earlier.

  • ‘It’s all in your head.’ What does that mean?

    Brian F. Mandell, MD, PhD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 637-638;
    • DOI: https://doi.org/10.3949/ccjm.93b.11026
    • For years I had paid little overt attention to the placebo effect, other than realizing that it needed to be considered when interpreting treatment effect size in clinical trials.

  • In Reply: Primary aldosteronism

    George Thomas, MD
    • Cleveland Clinic Journal of Medicine November 2026, 93 (11) 641-642;
    • DOI: https://doi.org/10.3949/ccjm.93c.11002
Loading

Altmetrics Data

Altmetric tracks attention and engagement of scholarly articles.

No Altmetric data available.